相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
Tao Liu et al.
CANCER RESEARCH (2009)
GPU Accelerated Support Vector Machines for Mining High-Throughput Screening Data
Quan Liao et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Recent progress in the biology and physiology of sirtuins
Toren Finkel et al.
NATURE (2009)
How does SIRT1 affect metabolism, senescence and cancer?
Christopher L. Brooks et al.
NATURE REVIEWS CANCER (2009)
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator
Sonia Lain et al.
CANCER CELL (2008)
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
Jie Ma et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Chemical probes for histone-modifying enzymes
Philip A. Cole
NATURE CHEMICAL BIOLOGY (2008)
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Huafeng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging
Boris A. Hadaschik et al.
BJU INTERNATIONAL (2007)
Kinetic and mutational studies of the number of interacting divalent cations required by bacterial and human methionine Aminopeptidases
Xiaoyi V. Hu et al.
BIOCHEMISTRY (2007)
Sirt1 modulates premature senescence-like phenotype in human endothelial cells
Hidetaka Ota et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
SIRT1 controls endothelial angiogenic functions during vascular growth
Michael Potente et al.
GENES & DEVELOPMENT (2007)
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore
Joseph P. Marino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression
Xiaoyi Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity
Xiaochun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A clinical drug library screen identifies astemizole as an antimalarial agent
Curtis R. Chong et al.
NATURE CHEMICAL BIOLOGY (2006)
Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding
George S. Sheppard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Alejandro Vaquero et al.
GENES & DEVELOPMENT (2006)
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes
B Heltweg et al.
CANCER RESEARCH (2006)
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage
JM Solomon et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins
E Michishita et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells
S Roy et al.
CELL DEATH AND DIFFERENTIATION (2005)
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
A Brunet et al.
SCIENCE (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Proteomics-based target identification - Bengamides as a new class of methionine aminopeptidase inhibitors
H Towbin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin
JS Shim et al.
CHEMISTRY & BIOLOGY (2003)
The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase
BJ North et al.
MOLECULAR CELL (2003)
Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence
E Langley et al.
EMBO JOURNAL (2002)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG
B Murugasu-Oei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest
JRJ Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cellular senescence: Mitotic clock or culture shock?
CJ Sherr et al.
CELL (2000)
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
M Pearson et al.
NATURE (2000)
Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
TNP-470: an angiogenesis inhibitor in clinical development for cancer
EA Kruger et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
分享论文
